Status:
UNKNOWN
Multifactorial Intervention on Diabetes (MIDiab Study)
Lead Sponsor:
Shandong Provincial Hospital
Collaborating Sponsors:
The Affiliated Hospital of Qingdao University
The First Hospital of Jilin University
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
35-75 years
Phase:
PHASE4
Brief Summary
The prevalence of diabetes mellitus has been increasing in recent decades in China, and vascular complication is the major burden in patients with type 2 diabetes. Previous studies demonstrated that o...
Eligibility Criteria
Inclusion
- 35-75 years old;
- diagnosed as type 2 diabetes according to the criteria of the World Health Organization in 1999.
Exclusion
- type 1 diabetes，specific types of diabetes，gestational diabetes or pregestational diabetes;
- acute cardiovascular or cerebrovascular accidents within past 3 months;
- severe hepatic or renal dysfunction;
- malignant tumor;
- allergic history or contraindication for any drugs in trials;
- taking part in other clinical trials;
- obviously poor compliance.
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
6300 Patients enrolled
Trial Details
Trial ID
NCT03430284
Start Date
April 1 2018
End Date
December 31 2022
Last Update
July 9 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Shandong Provincial Hospital
Jinan, Shandong, China, 250021
2
Shandong Provincial Hospital
Jinan, Shandong, China